4D Molecular Therapeutics Inc Contracts & Agreements

48 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Stock Option Grant Notice and Stock Option Agreement under the 2025 Employment Inducement Award Plan
4D Molecular Therapeutics Inc
Biotechnology
2025
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2025 Employment Inducement Award Plan
4D Molecular Therapeutics Inc
Biotechnology
2025
2025 Employment Inducement Award Plan
4D Molecular Therapeutics Inc
Biotechnology
2025
Description of Securities of the Registrant
4D Molecular Therapeutics Inc
Biotechnology
2025
Form of Pre-Funded Warrant issued in conjunction with December 2024 exchange
Warrant Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2024
Form of Pre-Funded Warrant issued in conjunction with November 2024 exchange
Warrant Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2024
Sales Agreement, dated June 7, 2024, by and between the Company and Leerink Partners LLC
Sales Agreements
4D Molecular Therapeutics Inc
Biotechnology
NY
2024
Amended and Restated Change in Control and Severance Agreement, dated June 23, 2023 by and between Robert Kim and the Registrant
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2024
Change in Control and Severance Agreement, dated September 22, 2021, by and between Scott Bizily and the Registrant
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2024
Change in Control and Severance Agreement, dated August 29, 2023, by and between Uneek Mehra and the Registrant
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2024
Offer Letter, dated September 4, 2023, between Uneek Mehra and the Registrant
4D Molecular Therapeutics Inc
Biotechnology
2024
Form of Pre-Funded Warrant
Warrant Agreements
4D Molecular Therapeutics Inc
Biotechnology
NY
2024
Underwriting Agreement, dated as of February 6, 2024, among 4D Molecular Therapeutics, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc., Jefferies LLC and Barclays Capital...
Underwriting Agreements
4D Molecular Therapeutics Inc
Biotechnology
2024
License Agreement between the Registrant and Astellas Gene Therapies, Inc., dated as of July 5, 2023
License Agreements
4D Molecular Therapeutics Inc
Biotechnology
NY
2023
Underwriting Agreement, dated as of May 4, 2023, among 4D Molecular Therapeutics, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Evercore Group, L.L.C
Underwriting Agreements
4D Molecular Therapeutics Inc
Biotechnology
2023
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
4D Molecular Therapeutics Inc
Biotechnology
2022
Description of Securities of the Registrant
4D Molecular Therapeutics Inc
Biotechnology
DE
2022
Change in Control and Severance Agreement, dated September 22, 2021, by and between Fred Kamal and 4D Molecular Therapeutics, Inc
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2021
Form of Underwriting Agreement
Underwriting Agreements
4D Molecular Therapeutics Inc
Biotechnology
2021
Change in Control and Severance Agreement, dated September 22, 2021, by and between Robert Stephen Fishman and 4D Molecular Therapeutics, Inc
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2021
Change in Control and Severance Agreement, dated September 22, 2021, by and between August Moretti and 4D Molecular Therapeutics, Inc
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2021
Change in Control and Severance Agreement, dated September 22, 2021, by and between David Kirn and 4D Molecular Therapeutics, Inc
Change of Control Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2021
Description of Securities of the Registrant
4D Molecular Therapeutics Inc
Biotechnology
DE
2021
Offer Letter, dated January 4, 2019 between August Moretti and the Registrant
4D Molecular Therapeutics Inc
Biotechnology
2020
Employment Agreement, dated January 15, 2019 between Peter Francis, M.D., Ph.D. and the Registrant
Employment Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Form of Underwriting Agreement
Underwriting Agreements
4D Molecular Therapeutics Inc
Biotechnology
2020
Form of Common Stock Certificate
Stock Agreements
4D Molecular Therapeutics Inc
Biotechnology
2020
Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto
Investor Rights Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
2020 Incentive Award Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2020 Incentive Award Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
2020 Employee Stock Purchase Plan
Stock Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Form of Indemnification Agreement for directors and officers
Indemnification Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
License Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
License Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Offer Letter, dated March 20, 2015 between David Kirn, M.D. and the Registrant
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2020 Incentive Award Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
License Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto
Investor Rights Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
2015 Equity Incentive Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Form of Stock Option Agreement under 2015 Equity Incentive Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2020
Collaboration and License Agreement, dated November 16, 2017, among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc
Collaboration Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Amended and Restated Collaboration and License Agreement, dated August 6, 2019, between the Registrant and uniQure biopharma B.V
Collaboration Agreements
4D Molecular Therapeutics Inc
Biotechnology
NY
2020
Collaboration and License Agreement, dated August 6, 2019, by and between the Registrant and uniQure biopharma B.V
Collaboration Agreements
4D Molecular Therapeutics Inc
Biotechnology
NY
2020
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California
License Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2020
Amended and Restated Investors Rights Agreement, dated as of August 27, 2018, among the Registrant and the investors party thereto
Investor Rights Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2019
Form of Stock Option Agreement under 2015 Equity Incentive Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
DE
2019
2015 Equity Incentive Plan
Bonus & Incentive Agreements
4D Molecular Therapeutics Inc
Biotechnology
CA
2019